These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. In vitro response of neuromuscular blockers after chronic carbamazepine treatment in rats. Nguyen A; Ramzan I Pharmazie; 2000 Dec; 55(12):957. PubMed ID: 11189879 [No Abstract] [Full Text] [Related]
45. [Problems of anesthesia in swine as experimental animals]. Picardi N; Monti M; Pasta V Ann Ital Chir; 1975-1976; 49(1-6):17-27. PubMed ID: 158325 [No Abstract] [Full Text] [Related]
46. Neuromuscular Blocking Agents During Electroconvulsive Therapy: Was the Crossover Design Appropriate and Valid? Daoud M Anesth Analg; 2017 Apr; 124(4):1370. PubMed ID: 28212212 [No Abstract] [Full Text] [Related]
47. Are non-depolarizing neuromuscular blocking agents innocuous for the neonates? Guay J Can J Anaesth; 2005 Feb; 52(2):213; author reply 213-4. PubMed ID: 15684271 [No Abstract] [Full Text] [Related]
54. [The problem of physico-chemical and pharmacological incompatibility of the products used in phleboclysis in resuscitation]. Arosio G; Mazzardi E; Bellini L; Rastrelli GF Minerva Anestesiol; 1976 Apr; 42(4):245-60. PubMed ID: 1018767 [No Abstract] [Full Text] [Related]
55. The priming principle: early development. Jones RM Br J Anaesth; 1990 Feb; 64(2):256. PubMed ID: 2138491 [No Abstract] [Full Text] [Related]
56. Fine tuning the priming principle. Foldes FF Anesthesiology; 1985 Nov; 63(5):560-1. PubMed ID: 2932040 [No Abstract] [Full Text] [Related]
57. Neuromuscular blocking agents. Dulin P; Williams C Crit Care Med; 1993 Nov; 21(11):1808-9. PubMed ID: 8222705 [No Abstract] [Full Text] [Related]